ClinicalTrials.Veeva

Menu

Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles (sildenafil)

F

farzaneh hojjat

Status and phase

Completed
Phase 4

Conditions

Frozen Embryo Transfer
Endometrial Preparation

Treatments

Drug: estradiol valerat
Drug: Sildenafil

Study type

Interventional

Funder types

Other

Identifiers

NCT01668446
rad123 (Other Identifier)
radvin123

Details and patient eligibility

About

The target of this study was an estimate the result of sildenafil on ultrasonographic endometrial thickness, endometrial pattern investigation estrogen level on the day of progesterone administration, Implantation rate and chemical pregnancy rate in frozen embryo transfer cycles .

Enrollment

2 patients

Sex

Female

Ages

20 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women > 40 years old,
  • history of endocrine disease
  • Hysteroscopic surgery
  • cardiovascular, renal and liver disease
  • hypotension( blood pressure < 90/50)
  • history of stroke or myocardial infarction
  • use of alcohol or substance

Exclusion criteria

A total of 80 patients with antecedent of poor endometrial response and had frozen embryo included in this study all women must to be < 40 years old,

  • no history of endocrine disease,
  • no Hysteroscopic surgery, had a high quality embryos no cardiovascular,
  • renal and liver disease and
  • no hypotension (blood pressure < 90/50) or
  • history of stroke or myocardial infarction and
  • don't use of alcohol or substance Patients with these conditions enter this study and based on randomized tables are divided in two groups.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

2 participants in 2 patient groups

sildenafil
Experimental group
Description:
One of two group to prepare the endometrium give estradiol by step up method with menstruation. From first to fourth day of menstrual cycle, estradiol valerat tablet 2 mg daily From Fifth to eighth day of menstrual cycle, estradiol valerat tablet 4 mg daily From Ninth to twelfth day of menstrual , estradiol valerat tablet 6 mg daily The second group in addition to the above treatment protocol from First day of cycle until day of starting progesterone will be given sildenafil tablets(50 mg) daily.
Treatment:
Drug: Sildenafil
Sildenafil and estradiol valerat
Experimental group
Description:
One of two group to prepare the endometrium give estradiol by step up method with menstruation. From first to fourth day of menstrual cycle, estradiol valerat tablet 2 mg daily From Fifth to eighth day of menstrual cycle, estradiol valerat tablet 4 mg daily From Ninth to twelfth day of menstrual , estradiol valerat tablet 6 mg daily The second group in addition to the above treatment protocol from First day of cycle until day of starting progesterone will be given sildenafil tablets(50 mg) daily.
Treatment:
Drug: estradiol valerat
Drug: Sildenafil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems